Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deniz Peker

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Molecular and Clinical Oncology|February 14, 2018
Therapy-associated myelodysplastic syndrome with monosomy 7 arising in a Muir-Torre Syndrome patient carrying <i>SETBP1</i> mutationDavid Ullman, Erin Baumgartner, Nicholas Wnukowski, et al.
Academic Pathology|August 21, 2025
Women faculty achieve promotion to full professor equivalent to men faculty in a subset of US academic pathology departmentsDebra G B Leonard, Melvin Limson, Valerie A Fitzhugh, et al.
The American Journal of Pathology|September 21, 2016
Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in BoneTimothy N Trotter, Justin T Gibson, Tshering Lama Sherpa, et al.
Case Reports in Pathology|June 1, 2018
Postradiation Histiocytic Sarcoma in the Setting of Muir-Torre SyndromeErin Baumgartner, David Ullman, Jeffrey Adam Jones, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 16, 2015
Is Low Positive JAK2 V617F Mutation Test Result Clinically Significant?: Multi-Institutional StudyXiaojun Wu, Joong Won Lee, Deniz Peker, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2018
Clinicopathologic Features and Clinical Outcome Differences in De Novo Versus Secondary Histiocytic Sarcomas: A Multi-institutional Experience and Review of the LiteratureDevin R Broadwater, Joanna L Conant, David R Czuchlewski, et al.
International Journal of Hematology|September 12, 2014
Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: a single institution experienceDeniz Peker, Vishwas Parekh, Ravikumar Paluri, et al.
Histopathology|March 28, 2019
Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemiaDavid I Ullman, David Dorn, Jeffery A Jones, et al.
Current Oncology Reports|May 10, 2023
Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative DisorderMichelle Lee, Aseala Abousaud, R Andrew Harkins, et al.
Oncotarget|February 6, 2016
Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cellsJuan Li, Qianying Pan, Patrick D Rowan, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Molecular and Clinical Oncology|February 14, 2018
Therapy-associated myelodysplastic syndrome with monosomy 7 arising in a Muir-Torre Syndrome patient carrying <i>SETBP1</i> mutationDavid Ullman, Erin Baumgartner, Nicholas Wnukowski, et al.
Academic Pathology|August 21, 2025
Women faculty achieve promotion to full professor equivalent to men faculty in a subset of US academic pathology departmentsDebra G B Leonard, Melvin Limson, Valerie A Fitzhugh, et al.
The American Journal of Pathology|September 21, 2016
Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in BoneTimothy N Trotter, Justin T Gibson, Tshering Lama Sherpa, et al.
Case Reports in Pathology|June 1, 2018
Postradiation Histiocytic Sarcoma in the Setting of Muir-Torre SyndromeErin Baumgartner, David Ullman, Jeffrey Adam Jones, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 16, 2015
Is Low Positive JAK2 V617F Mutation Test Result Clinically Significant?: Multi-Institutional StudyXiaojun Wu, Joong Won Lee, Deniz Peker, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2018
Clinicopathologic Features and Clinical Outcome Differences in De Novo Versus Secondary Histiocytic Sarcomas: A Multi-institutional Experience and Review of the LiteratureDevin R Broadwater, Joanna L Conant, David R Czuchlewski, et al.
International Journal of Hematology|September 12, 2014
Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: a single institution experienceDeniz Peker, Vishwas Parekh, Ravikumar Paluri, et al.
Histopathology|March 28, 2019
Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemiaDavid I Ullman, David Dorn, Jeffery A Jones, et al.
Current Oncology Reports|May 10, 2023
Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative DisorderMichelle Lee, Aseala Abousaud, R Andrew Harkins, et al.
Oncotarget|February 6, 2016
Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cellsJuan Li, Qianying Pan, Patrick D Rowan, et al.
Pageof 5